{"text": "$abt weekly view URL"}
{"text": "abbott-alere deal to go ahead $abt URL"}
{"text": "jefferies group comments on abbott laboratories\u00a1\u00af fy2021 earnings $abt URL"}
{"text": "jefferies group comments on abbott laboratories\u00a1\u00af fy2021 earnings $abt URL #stocks"}
{"text": "jefferies group comments on abbott laboratories\u00a1\u00af fy2021 earnings $abt URL"}
{"text": "jefferies group comments on abbott laboratories\u00a1\u00af fy2021 earnings $abt URL"}
{"text": "rt AT_USER merger challenges, fda concerns push abbott shares down despite strong first quarter $abt URL via\u00a1\u00ad"}
{"text": "a.r.t. advisors llc acquires new position in abbott laboratories $abt URL"}
{"text": "a.r.t. advisors llc acquires new position in abbott laboratories $abt URL"}
{"text": "silvercrest asset management group llc raises position in abbott laboratories $abt URL"}
{"text": "silvercrest asset management group llc raises position in abbott laboratories $abt URL"}
{"text": "rt AT_USER $abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "$abt morgan stanley reiterates equal weight rating, $42 pt URL"}
{"text": "rt AT_USER watch now: ceo miles d. white on $abt #1q17 results. URL URL"}
{"text": "rt AT_USER $abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "ct financial advisors llc has $140,000 position in abbott laboratories $abt URL"}
{"text": "brief-#abbott cfo says \"we're not going to really be in a good position to give a lot of det... read more: URL $abt"}
{"text": "rt AT_USER $abt ceo: we expect to deliver on our double-digit ongoing eps growth target for the full year. URL"}
{"text": "rt AT_USER $abt ceo: the combination with st. jude positions abbott with one of the strongest new product pipelines in the industry. h\u00a1\u00ad"}
{"text": "rt AT_USER $abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "fy2018 eps estimates for abbott laboratories raised by jefferies group $abt URL"}
{"text": "fy2018 eps estimates for abbott laboratories raised by jefferies group $abt URL"}
{"text": "fy2018 eps estimates for abbott laboratories raised by jefferies group $abt URL"}
{"text": "abbott laboratories $abt position decreased by northstar group inc. URL"}
{"text": "rt AT_USER $abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "rt AT_USER $abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "rt AT_USER watch now: ceo miles d. white on $abt #1q17 results. URL URL"}
{"text": "rt AT_USER $abt ceo: we expect to deliver on our double-digit ongoing eps growth target for the full year. URL"}
{"text": "#abbott tops q1 earnings on strong epd, medical device. read more: URL $abt"}
{"text": "rt AT_USER $abt reports 1q results; sales, eps ahead of street estimates URL URL"}
{"text": "#abbott laboratories tops q1 earnings &amp; sales estimates. read more: URL $abt"}
{"text": "watch now: ceo miles d. white on $abt #1q17 results. URL URL"}
{"text": "abbott laboratories $abt receives equal weight rating from morgan stanley URL"}
{"text": "abbott laboratories's equal weight rating reiterated at morgan stanley. $42.00 pt. URL $abt #abt"}
{"text": "abbott laboratories $abt receives equal weight rating from morgan stanley URL"}
{"text": "rt AT_USER merger challenges, fda concerns push abbott shares down despite strong first quarter $abt URL via\u00a1\u00ad"}
{"text": "rt AT_USER $abt ceo: the combination with st. jude positions abbott with one of the strongest new product pipelines in the industry. h\u00a1\u00ad"}
{"text": "rt AT_USER #abbott sees #alere as challenging 'fixer-upper' after revised deal URL via AT_USER $abt $alr"}
{"text": "rt AT_USER #abbott sees #alere as challenging 'fixer-upper' after revised deal URL via AT_USER $abt $alr"}
{"text": "brokerages expect abbott laboratories $abt will announce quarterly sales of $6.11 billion URL"}
{"text": "#abbott q1 dx revenues up 4 percent amid strong overall performance. read more: URL $abt"}
{"text": "merger challenges, fda concerns push abbott shares down despite strong first quarter $abt URL via AT_USER"}
{"text": "brokerages expect abbott laboratories $abt to announce $0.43 eps URL"}
{"text": "brokerages expect abbott laboratories $abt will announce quarterly sales of $6.11 billion URL"}
{"text": "abbott (abt) tops q1 earnings on strong epd, medical device URL $abt URL"}
{"text": "abbott laboratories $abt announces earnings results URL"}
{"text": "abbott laboratories $abt issues quarterly  earnings results, beats expectations by $0.05 eps URL"}
{"text": "abbott laboratories $abt issues quarterly  earnings results, beats expectations by $0.05 eps URL"}
{"text": "abbott laboratories $abt issues quarterly earnings results, beats expectations by $0.05 eps URL"}
{"text": "abbott laboratories $abt issues quarterly  earnings results, beats expectations by $0.05 eps URL"}
{"text": "rt AT_USER $abt very big beat, strong performance in diagnostics, med-devices while nutrition lagged on weak chinese infant formula m\u00a1\u00ad"}
{"text": "abbott laboratories  reiterated rating by stifel nicolaus (ranked 40th) to buy $abt #abt URL"}
{"text": "abbott laboratories  lower price target by jefferies &amp; co (ranked 20th) to $50 as buy $abt #abt URL"}
{"text": "$abt biggest beat in medical devices ~+120m neuromodulation boom/  &gt; 50% sales in scs burst +ve for $nvro -\u00a1\u00ad URL"}
{"text": "rt AT_USER $abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "rt AT_USER $abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "abbott laboratories announces earnings. $0.48 eps. beats estimates. $6.34b revenue. URL $abt #abt"}
{"text": "salphatrending: abbott laboratories' (abt) ceo miles white on q1 2017 results - earnings call transcript URL $abt"}
{"text": "#abbott sees #alere as challenging 'fixer-upper' after revised deal URL via AT_USER $abt $alr"}
{"text": "$abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "abbott laboratories' (abt) ceo miles white on q1 2017 results - earnings call transcript URL $abt"}
{"text": "10 stocks to watch for april 19, 2017 URL $abt $axp $csx #premarket via AT_USER"}
{"text": "rt AT_USER the passive dgi portfolio: review and updates URL $abt $adp $afl $apd $cl $clx $cop $csco $cvx $dwx $em\u00a1\u00ad"}
{"text": "rt AT_USER $abt ceo: we expect to deliver on our double-digit ongoing eps growth target for the full year. URL"}
{"text": "rt AT_USER the passive dgi portfolio: review and updates URL $abt $adp $afl $apd $cl $clx $cop $csco $cvx $dwx $\u00a1\u00ad"}
{"text": "the passive dgi portfolio: review and updates URL $abt $adp $afl $apd $cl $clx $cop $csco $cvx $dwx $emr $hcp $intc"}
{"text": "the passive dgi portfolio: review and updates URL $abt $adp $afl $apd $cl $clx $cop $csco $cvx $dwx $emr $hcp $intc"}
{"text": "the passive dgi portfolio: review and updates URL $abt $adp $afl $apd $cl $clx $cop $csco $cvx $dwx $emr $hcp $intc"}
{"text": "rt AT_USER abbott laboratories beats on earnings and revenue $abt #stockmarket #stocktrading URL URL"}
{"text": "rt AT_USER up gappers- $rare $imgn $srne $nvls $lrcx $adtn $txmd $idxg $dxtr $innl $rbs $mt $ms $aks $ing $lyg $mnkd $fit $abt $db\u00a1\u00ad"}
{"text": "#abbott's profit rises 33 percent after st. jude medical deal. read more: URL $abt"}
{"text": "rt AT_USER $abt ceo: we expect to deliver on our double-digit ongoing eps growth target for the full year. URL"}
{"text": "#abbott delivers street-crushing q1 following st. jude buy. read more: URL $abt"}
{"text": "$abt said on earnings call php heart pump issue unresolved and off the market still no competition for $abmd impella and clear runway"}
{"text": "#abbott's 1q results top wall street's expectations. read more: URL $abt"}
{"text": "rt AT_USER a new player has emerged to nip at $abt &amp; nestle in addition to its efforts in better for you bev space wow  URL"}
{"text": "china weighs on #abbott infant formula sales. read more: URL $abt"}
{"text": "$abt q1 2017 earnings infographic presentation is now available #earnings URL"}
{"text": "#abbott tops q1 #earnings on strong epd, medical device $abt also $holx $ign $ssh URL"}
{"text": "rt AT_USER $abt ceo: the combination with st. jude positions abbott with one of the strongest new product pipelines in the industry. h\u00a1\u00ad"}
{"text": "rt AT_USER $abt ceo: we expect to deliver on our double-digit ongoing eps growth target for the full year. URL"}
{"text": "abbott delivers street-crushing q1 following st. jude buy $abt $jnj URL"}
{"text": "rt AT_USER up gappers- $rare $imgn $srne $nvls $lrcx $adtn $txmd $idxg $dxtr $innl $rbs $mt $ms $aks $ing $lyg $mnkd $fit $abt $db\u00a1\u00ad"}
{"text": "brief-#abbott q1 adjusted earnings per share $0.48 from continuing operations. read more: URL $abt"}
{"text": "3 big stock charts for wednesday: $isrg $abt and $hban - URL"}
{"text": "3 big stock charts for wednesday: $isrg $abt and $hban - URL"}
{"text": "with st. jude medical in mix, #abbott reports revenue growth. read more: URL $abt"}
{"text": "stocks in play: $abt $fult $ltxb URL 15% off with our promo code: globalbdtrade15"}
{"text": "$gnc $abt $ual $ms tuesday morn trades blog + $1,014 profits  URL"}
{"text": "up gappers- $rare $imgn $srne $nvls $lrcx $adtn $txmd $idxg $dxtr $innl $rbs $mt $ms $aks $ing $lyg $mnkd $fit $abt\u00a1\u00ad URL"}
{"text": "abbott laboratories posts better-than-expected earnings results $abt URL"}
{"text": "abbott laboratories posts better-than-expected earnings results $abt URL"}
{"text": "rt AT_USER $abt says responding to fda warning letter on batteries"}
{"text": "$abt solid report boosted by biggest beat in mediocal devices ~120m unit  neuromodulation boom $ihi - $syk $zmh $bdx $nvro $pen"}
{"text": "long $abt URL"}
{"text": "rt AT_USER $abt first quarter results reflect a strong start to the year. #1q17 URL"}
{"text": "wondering about risks of $abt? the 21-day volatility is 3.21% URL"}
{"text": "we calculated 63-day expected return of $abt for you: 6.07% URL"}
{"text": "$abt -  currently at resistance 1 and looking at further downside. #bear"}
{"text": "customized research for $adms vs. $abt! URL"}
